Selected research
Industry Growth & Trends
Global Nicotine Gums and Lozenges Industry Growth and Trends Forecast to 2032
Market perspective
The global Nicotine Gums and Lozenges market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Nicotine Gums and Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Nicotine Gums and Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nicotine Gums and Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Nicotine Gums and Lozenges include Novartis, Perrigo Company, Pfizer, Fertin Pharma, Johnson & Johnson, Cipla, Alkalon, GSK and Reynolds American, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Nicotine Gums and Lozenges market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Nicotine Gums and Lozenges market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nicotine Gums and Lozenges market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nicotine Gums and Lozenges.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Nicotine Gums and Lozenges market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Nicotine Gums and Lozenges Market by Company
Novartis
Perrigo Company
Pfizer
Fertin Pharma
Johnson & Johnson
Cipla
Alkalon
GSK
Reynolds American
Dr. Reddy's Laboratories
Nicotine Gums and Lozenges Segment by Type
2 mg/piece
4 mg/piece
Other
Nicotine Gums and Lozenges Segment by Application
Withdrawal Clinics
Medical Practice
Individual Smokers
Others
Nicotine Gums and Lozenges Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotine Gums and Lozenges market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nicotine Gums and Lozenges and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotine Gums and Lozenges.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nicotine Gums and Lozenges manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Nicotine Gums and Lozenges in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2 mg/piece
- 4 mg/piece
- Other
Applications
- Withdrawal Clinics
- Medical Practice
- Individual Smokers
- Others
Companies covered
- Novartis
- Perrigo Company
- Pfizer
- Fertin Pharma
- Johnson & Johnson
- Cipla
- Alkalon
- GSK
- Reynolds American
- Dr. Reddy's Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Nicotine Gums and Lozenges Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Nicotine Gums and Lozenges Sales Estimates and Forecasts (2021-2032)
- 1.3 Nicotine Gums and Lozenges Market by Type
- 1.3.1 2 mg/piece
- 1.3.2 4 mg/piece
- 1.3.3 Other
- 1.4 Global Nicotine Gums and Lozenges Market Size by Type
- 1.4.1 Global Nicotine Gums and Lozenges Market Size Overview by Type (2021-2032)
- 1.4.2 Global Nicotine Gums and Lozenges Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Nicotine Gums and Lozenges Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Nicotine Gums and Lozenges Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Nicotine Gums and Lozenges Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Nicotine Gums and Lozenges Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Nicotine Gums and Lozenges Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Nicotine Gums and Lozenges Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Nicotine Gums and Lozenges Industry Trends
- 2.2 Nicotine Gums and Lozenges Industry Drivers
- 2.3 Nicotine Gums and Lozenges Industry Opportunities and Challenges
- 2.4 Nicotine Gums and Lozenges Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Nicotine Gums and Lozenges Revenue (2021-2026)
- 3.2 Global Top Players by Nicotine Gums and Lozenges Sales (2021-2026)
- 3.3 Global Top Players by Nicotine Gums and Lozenges Price (2021-2026)
- 3.4 Global Nicotine Gums and Lozenges Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Nicotine Gums and Lozenges Major Company Production Sites & Headquarters
- 3.6 Global Nicotine Gums and Lozenges Company, Product Type & Application
- 3.7 Global Nicotine Gums and Lozenges Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Nicotine Gums and Lozenges Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Nicotine Gums and Lozenges Players Market Share by Revenue in 2025
- 3.8.3 2025 Nicotine Gums and Lozenges Tier 1, Tier 2, and Tier 3
4 Nicotine Gums and Lozenges Regional Status and Outlook
- 4.1 Global Nicotine Gums and Lozenges Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Nicotine Gums and Lozenges Historic Market Size by Region
- 4.2.1 Global Nicotine Gums and Lozenges Sales in Volume by Region (2021-2026)
- 4.2.2 Global Nicotine Gums and Lozenges Sales in Value by Region (2021-2026)
- 4.2.3 Global Nicotine Gums and Lozenges Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Nicotine Gums and Lozenges Forecasted Market Size by Region
- 4.3.1 Global Nicotine Gums and Lozenges Sales in Volume by Region (2027-2032)
- 4.3.2 Global Nicotine Gums and Lozenges Sales in Value by Region (2027-2032)
- 4.3.3 Global Nicotine Gums and Lozenges Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nicotine Gums and Lozenges by Application
- 5.1 Nicotine Gums and Lozenges Market by Application
- 5.1.1 Withdrawal Clinics
- 5.1.2 Medical Practice
- 5.1.3 Individual Smokers
- 5.1.4 Others
- 5.2 Global Nicotine Gums and Lozenges Market Size by Application
- 5.2.1 Global Nicotine Gums and Lozenges Market Size Overview by Application (2021-2032)
- 5.2.2 Global Nicotine Gums and Lozenges Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Nicotine Gums and Lozenges Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Nicotine Gums and Lozenges Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Nicotine Gums and Lozenges Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Nicotine Gums and Lozenges Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Nicotine Gums and Lozenges Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Nicotine Gums and Lozenges Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Novartis
- 6.1.1 Novartis Company Information
- 6.1.2 Novartis Business Overview
- 6.1.3 Novartis Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Novartis Nicotine Gums and Lozenges Product Portfolio
- 6.1.5 Novartis Recent Developments
- 6.2 Perrigo Company
- 6.2.1 Perrigo Company Company Information
- 6.2.2 Perrigo Company Business Overview
- 6.2.3 Perrigo Company Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Perrigo Company Nicotine Gums and Lozenges Product Portfolio
- 6.2.5 Perrigo Company Recent Developments
- 6.3 Pfizer
- 6.3.1 Pfizer Company Information
- 6.3.2 Pfizer Business Overview
- 6.3.3 Pfizer Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Pfizer Nicotine Gums and Lozenges Product Portfolio
- 6.3.5 Pfizer Recent Developments
- 6.4 Fertin Pharma
- 6.4.1 Fertin Pharma Company Information
- 6.4.2 Fertin Pharma Business Overview
- 6.4.3 Fertin Pharma Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Fertin Pharma Nicotine Gums and Lozenges Product Portfolio
- 6.4.5 Fertin Pharma Recent Developments
- 6.5 Johnson & Johnson
- 6.5.1 Johnson & Johnson Company Information
- 6.5.2 Johnson & Johnson Business Overview
- 6.5.3 Johnson & Johnson Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Johnson & Johnson Nicotine Gums and Lozenges Product Portfolio
- 6.5.5 Johnson & Johnson Recent Developments
- 6.6 Cipla
- 6.6.1 Cipla Company Information
- 6.6.2 Cipla Business Overview
- 6.6.3 Cipla Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Cipla Nicotine Gums and Lozenges Product Portfolio
- 6.6.5 Cipla Recent Developments
- 6.7 Alkalon
- 6.7.1 Alkalon Company Information
- 6.7.2 Alkalon Business Overview
- 6.7.3 Alkalon Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Alkalon Nicotine Gums and Lozenges Product Portfolio
- 6.7.5 Alkalon Recent Developments
- 6.8 GSK
- 6.8.1 GSK Company Information
- 6.8.2 GSK Business Overview
- 6.8.3 GSK Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 GSK Nicotine Gums and Lozenges Product Portfolio
- 6.8.5 GSK Recent Developments
- 6.9 Reynolds American
- 6.9.1 Reynolds American Company Information
- 6.9.2 Reynolds American Business Overview
- 6.9.3 Reynolds American Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Reynolds American Nicotine Gums and Lozenges Product Portfolio
- 6.9.5 Reynolds American Recent Developments
- 6.10 Dr. Reddy's Laboratories
- 6.10.1 Dr. Reddy's Laboratories Company Information
- 6.10.2 Dr. Reddy's Laboratories Business Overview
- 6.10.3 Dr. Reddy's Laboratories Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Dr. Reddy's Laboratories Nicotine Gums and Lozenges Product Portfolio
- 6.10.5 Dr. Reddy's Laboratories Recent Developments
7 North America by Country
- 7.1 North America Nicotine Gums and Lozenges Sales by Country
- 7.1.1 North America Nicotine Gums and Lozenges Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Nicotine Gums and Lozenges Sales by Country (2021-2026)
- 7.1.3 North America Nicotine Gums and Lozenges Sales Forecast by Country (2027-2032)
- 7.2 North America Nicotine Gums and Lozenges Market Size by Country
- 7.2.1 North America Nicotine Gums and Lozenges Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Nicotine Gums and Lozenges Market Size by Country (2021-2026)
- 7.2.3 North America Nicotine Gums and Lozenges Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Nicotine Gums and Lozenges Sales by Country
- 8.1.1 Europe Nicotine Gums and Lozenges Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Nicotine Gums and Lozenges Sales by Country (2021-2026)
- 8.1.3 Europe Nicotine Gums and Lozenges Sales Forecast by Country (2027-2032)
- 8.2 Europe Nicotine Gums and Lozenges Market Size by Country
- 8.2.1 Europe Nicotine Gums and Lozenges Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Nicotine Gums and Lozenges Market Size by Country (2021-2026)
- 8.2.3 Europe Nicotine Gums and Lozenges Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Nicotine Gums and Lozenges Sales by Country
- 9.1.1 Asia-Pacific Nicotine Gums and Lozenges Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Nicotine Gums and Lozenges Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Nicotine Gums and Lozenges Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Nicotine Gums and Lozenges Market Size by Country
- 9.2.1 Asia-Pacific Nicotine Gums and Lozenges Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Nicotine Gums and Lozenges Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Nicotine Gums and Lozenges Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Nicotine Gums and Lozenges Sales by Country
- 10.1.1 South America Nicotine Gums and Lozenges Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Nicotine Gums and Lozenges Sales by Country (2021-2026)
- 10.1.3 South America Nicotine Gums and Lozenges Sales Forecast by Country (2027-2032)
- 10.2 South America Nicotine Gums and Lozenges Market Size by Country
- 10.2.1 South America Nicotine Gums and Lozenges Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Nicotine Gums and Lozenges Market Size by Country (2021-2026)
- 10.2.3 South America Nicotine Gums and Lozenges Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Nicotine Gums and Lozenges Sales by Country
- 11.1.1 Middle East and Africa Nicotine Gums and Lozenges Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Nicotine Gums and Lozenges Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Nicotine Gums and Lozenges Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Nicotine Gums and Lozenges Market Size by Country
- 11.2.1 Middle East and Africa Nicotine Gums and Lozenges Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Nicotine Gums and Lozenges Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Nicotine Gums and Lozenges Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Nicotine Gums and Lozenges Value Chain Analysis
- 12.1.1 Nicotine Gums and Lozenges Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Nicotine Gums and Lozenges Production Mode & Process
- 12.2 Nicotine Gums and Lozenges Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Nicotine Gums and Lozenges Distributors
- 12.2.3 Nicotine Gums and Lozenges Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst